证券记录 · 已归档季度
RIGL
Rigel Pharmaceuticals, Inc. · Healthcare · Biotechnology
12被追踪持有人
+2Δ持有人
4.47M持有股份
$83.70M报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +20.0% ·
股份流向 +5.7% ·
净新建仓位 +16.7%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | -2 | 9.47M | $370.29M | +3 | −5 |
| Q1 2026 | 77 | -10 | 11.13M | $301.00M | — | −10 |
| Q4 2025 | 86 | +1 | 11.49M | $491.92M | +1 | — |
| Q3 2025 | 18 | +3 | 6.87M | $194.53M | +3 | — |
| Q2 2025 | 12 | +2 | 4.47M | $83.70M | +2 | — |
| Q1 2025 | 7 | -1 | 1.55M | $27.81M | +2 | −3 |
| Q4 2024 | 8 | +4 | 1.41M | $23.66M | +5 | −1 |
| Q3 2024 | 3 | -2 | 554.02K | $8.97M | — | −2 |
| Q2 2024 | 5 | — | 605.71K | $4.98M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 1.63M | — | $30.45M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 1.05M | — | $19.72M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 1.05M | — | $19.72M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 1.05M | — | $19.72M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (被动) | 600.18K | -5.8% | $11.24M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 415.61K | +1.1% | $7.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (被动) | 415.61K | +1.1% | $7.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Marshall Wace ✦ | 368.95K | +74.2% | $6.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 368.95K | +74.2% | $6.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 236.45K | +17.6% | $4.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Wellington Management ✦ | 63.82K | +3.9% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 63.82K | +3.9% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 63.82K | +3.9% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Two Sigma Investments ✦ | 38.34K | +202.4% | $718,146 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Millennium Management ✦ | 31.26K | 新增 | $585,481 | 0.0% | New | 1 | SEC ↗ |
| 24 | Arrowstreet Capital ✦ | 21.98K | 新增 | $411,742 | 0.0% | New | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 10.04K | -5.5% | $188,012 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 10.04K | -5.5% | $188,012 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 10.04K | -5.5% | $188,012 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 10.04K | -5.5% | $188,012 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 10.04K | -5.5% | $188,012 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 3.39K | — | $63,552 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Fidelity (FMR) ✦ | 3.39K | — | $63,552 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $585,481 | 0.0% |
| Arrowstreet Capital | $411,742 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 146 持有人, 15.81M 股份, $391.97M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据